brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network

WP-Cumulus by Roy Tanck and Luke Morton requires Flash Player 9 or better.

dow jones statistics ¤ dawson james camh ¤ comcast analyst ratings goldman ¤ biologic equity research ¤ google quartalszahlen ¤ penn west citrix ¤ pennwest citrix ¤ ladenburg thalmann djsp ¤ celestica analysts ratings ¤ raiffeisen centrobank ag rating ¤ sandisk quartalszahlen ¤ penn west citrix login ¤ upgrade dupont ¤ market maker id ¤ upgrade mosaic ¤ comcast ¤ mcdonalds bond rating ¤ mitel analyst ¤ mitel shares downgraded ¤ %22arctic slope regional corp%22 or %22boeing defense%22 or %22booz allen hamilton%22 or %22call henry%22 or %22ch2m hill%22 or chenega or %22chugach alaska corp%22 or %22day and zimmerman%22 or ¤
recommendation ¤ 2010 ¤ debt ¤ citrix ¤ mitel ¤ for ¤ wunderlich ¤ stifel ¤ barclays ¤ renhe ¤ rating ¤ pennwest ¤ buy ¤ morgan ¤ dawson ¤ ratings ¤ nicolaus ¤ securities ¤ outperform ¤ dow ¤ upgraded ¤ analyst ¤ s&p ¤ analysts ¤ equity ¤ statistics ¤ penn ¤ report ¤ canaccord ¤ stock ¤ company ¤ west ¤ quartalszahlen ¤ group ¤ james ¤ upgrade ¤ downgraded ¤ baird ¤ market ¤ login ¤ downgrade ¤ oppenheimer ¤ maker ¤ capital ¤ dupont ¤ credit ¤ bond ¤ comments ¤ research ¤ energy ¤ ubs ¤ pdf ¤ rbc ¤ davidson ¤

www.brokerbase.ch network - market statistics

www.brokerbase.ch network - archived market statistics

www.brokerbase.ch High dividend yield stocks

Blogroll

Recent Posts

Wikio - Top Blog Add to Technorati Favorites Bloggeramt.de blogoscoop Blogverzeichnis - Blog Verzeichnis bloggerei.de Add to Google investinformer.de - TOP100 Investment Sites Listinus Toplisten

Human Genome Science

Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Friday, July 23rd, 2010

Human Genome (HGSI) Upgrade from Neutral to Outperform – Analyst rating from Robert W. Baird

Thursday, July 22nd, 2010

Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Thursday, July 22nd, 2010

Human Genome ( HGSI ) Upgrade from Neutral to Outperform($32) – Analyst rating from Robert W. Baird

Thursday, July 22nd, 2010

Human Genome ( HGSI ) Initial Recommendation Outperform – Analyst rating from RBC Capital Mkts

Wednesday, January 27th, 2010

Human Genome (HGSI) Initial Recommendation – Outperform – Analyst rating from RBC Capital Mkts

Wednesday, January 27th, 2010

Human Genome Sciences neues Kursziel – New Analyst Rating from UBS AG

Friday, January 15th, 2010

Human Genome Sciences Downgrade – New Analyst Rating from Goldman Sachs Group Inc.

Tuesday, January 12th, 2010

Human Genome Sciences Downgrade – New Analyst Rating from Goldman Sachs Group Inc.

Monday, January 11th, 2010

Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer

Tuesday, January 5th, 2010

Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer

Monday, January 4th, 2010

Human Genome Sciences overweight – New Analyst Rating from Morgan Stanley

Tuesday, December 22nd, 2009

Human Genome Sciences neues Kursziel – New Analyst Rating from Citigroup Corp.

Tuesday, December 1st, 2009

New Analyst Rating from JP Morgan Chase & Co. – Human Genome Sciences overweight

Saturday, October 31st, 2009

New Analyst Rating from JP Morgan Chase & Co. – Human Genome Sciences overweight

Friday, October 30th, 2009

Human Genome Sciences buy

Saturday, January 26th, 2008

Piper Jaffray stufen die Aktie von Human Genome Sciences von “neutral” auf “buy” hoch. Das Kursziel wird von 11 auf 9,00 USD gesenkt.

Human Genome Sciences outperform

Saturday, January 26th, 2008

Bear Stearns stufen die Aktie von Human Genome Sciences von “peer perform” auf “outperform” hoch.

Human Genome Sciences neues Kursziel

Saturday, January 26th, 2008

UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird von 17 auf 7,50 USD gesenkt.

Human Genome Sciences Downgrade

Saturday, January 26th, 2008

Die Analysten von Merrill Lnch stufen die Aktie von Human Genome Sciences von “buy” auf “neutral” zurück.

Human Genome Sciences neues Kursziel

Saturday, January 26th, 2008

JMP Securities stufen die Aktie von Human Genome Sciences unverändert mit “market outperform” ein. Das Kursziel wird von 15 auf 9,00 USD gesenkt.

Human Genome Sciences buy

Friday, January 11th, 2008

Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.

Human Genome Sciences buy

Friday, January 11th, 2008

UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.